TMPRSS11F inhibitors encompass a variety of chemical compounds that target the proteolytic functionality of TMPRSS11F, ultimately leading to its functional inhibition. Camostat Mesylate, Nafamostat Mesylate, and Gabexate Mesylate work by directly inhibiting the serine protease activity, which is central to TMPRSS11F's role in proteolytic cleavage processes. These inhibitors share a mechanism that involves the obstruction of TMPRSS11F's active site, restraining its ability to engage in proteolytic degradation of substrates. AEBSF Hydrochloride operates by irreversibly binding to serine residues within the active site, while Aprotinin and Leupeptin Hemisulfate provide reversible inhibition, forming complexes with TMPRSS11F that prevent substrate access. The inhibition of TMPRSS11F by these compounds is crucial as it impedes the protein's normal function and can affect the protease network within which TMPRSS11F operates.
In addition to direct inhibitors, there are compounds that influence TMPRSS11F activity indirectly by modulating the wider proteolytic environment. Pepstatin A, although primarily an aspartic protease inhibitor, and E-64, a cysteine protease inhibitor, contribute to the overall protease balance and can impact TMPRSS11F function indirectly. Marimastat and Ilomastat, known for their inhibition of matrix metalloproteases, may affect TMPRSS11F indirectly by altering the extracellular matrix, which could influence TMPRSS11F's accessibility or substrate availability. Similarly, Chymostatin acts on chymotrypsin-like serine proteases, which may indirectly reduce TMPRSS11F activity by altering the dynamic equilibrium of the protease network. Phosphoramidon, through its metalloprotease inhibition, could also lead to an indirect downregulation of TMPRSS11F's activity by changing the interactions within the protease cascade. These indirect mechanisms reflect the complex interplay between different protease families and how their inhibition can lead to a cascading effect, ultimately diminishing TMPRSS11F's activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
A serine protease inhibitor that hinders TMPRSS11F activity by directly inhibiting its proteolytic function. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Structurally similar to Camostat, it inhibits TMPRSS11F by blocking its serine protease domain. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A broad-spectrum serine protease inhibitor that decreases TMPRSS11F's enzymatic action. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
Irreversibly inhibits serine proteases, effectively reducing TMPRSS11F enzymatic cleavage activities. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A polypeptide inhibitor that forms stable complexes with serine proteases, inhibiting TMPRSS11F function. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Inhibits TMPRSS11F by reversibly binding to its serine protease active site. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
An irreversible cysteine protease inhibitor that indirectly affects TMPRSS11F by disrupting protease balance. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
A broad-spectrum metalloprotease inhibitor that can indirectly decrease TMPRSS11F function. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
Inhibits matrix metalloproteases, potentially reducing TMPRSS11F activity by altering extracellular matrix. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymotrypsin-like serine protease inhibitor that can indirectly inhibit TMPRSS11F activity. | ||||||